Pacific Biosciences Of California | PACB - 销售收入



金融业
股票价格
USD
资产
USD 751.85M
现金及等价物
USD 61M
销售成本
USD 28.9M
流动资产
USD 338.64M
流动负债
USD 68.81M
债务
USD 892.24M
股息收益率
0
EBIT
USD -53.19M
EBITDA
USD -35.4M
员工
796
EPS每股收益
USD -0.17
股本和储备
USD -33.21M
销售毛利
USD 15.74M
债务利息支出
USD 1.74M
贷款资金
USD 645.38M
市值
USD 306.8M
净收入
USD -40.37M
营业费用
USD 97.83M
营业利润
USD -53.19M
普通股股本
USD 301.96M
税前利润
USD -40.17M
销售收入
USD 44.65M
销售和管理费用
USD 37.24M
股票
USD 61.08M
贸易债权人
USD 19.22M
应收帐款人
USD 35.45M


销售 更改 日
Agilent USD 1.84B 37M 2026-03
Bruker USD 838.5M 15.1M 2026-06
Danaher USD 6.3B 350M 2026-06
General Electric Aerospace USD 12.63B 1.03B 2026-06
Illumina USD 1.16B 70M 2026-06
Myriad Genetics USD 190.7M 9.7M 2026-06
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Quidel USD 630.9M 10.9M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Standard Biotools USD 21.1M 2.7M 2026-03
Thermo Fisher Scientific USD 11.99B 980M 2026-06
Waters USD 1.64B 370M 2026-06